Skip to content
Stop using now Drug recall · FDA · Published August 11, 2023

Baxter Recalls Dianeal PD-2 Dialysis Solution Due to Sterility Risk

Baxter Healthcare recalls Dianeal PD-2 Peritoneal Dialysis Solution due to potential leaks from the Luer component, posing a sterility risk.

🇺🇸 FDA recall #D-1141-2023DrugBaxter ›
Take action

Contact the company

Recalling firmBaxter Healthcare Corporation1 Baxter Pkwy · Deerfield, IL 60015-4625
✎ GovInfoNow plain-language explainer

What happened, in plain English

Baxter Healthcare Corporation is recalling Dianeal PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose in 5000 mL AMBU-FLEX II containers. The recall addresses a lack of assurance of sterility caused by potential leaks originating from the Luer component. This issue affects specific lots distributed nationwide. Read more at govinfonow.com/recall/33212-baxter-recalls-dianeal-pd-2-dialysis-solution-due-to-sterility.

Source Summary by GovInfoNow · govinfonow.com/recall/33212-baxter-recalls-dianeal-pd-2-dialysis-solution-due-to-sterility · Updated October 9, 2026 · FDA enforcement record: FDA #D-1141-2023

Cite this page

“Baxter Recalls Dianeal PD-2 Dialysis Solution Due to Sterility Risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/33212-baxter-recalls-dianeal-pd-2-dialysis-solution-due-to-sterility. Based on FDA recall #D-1141-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1141-2023%22&limit=1).

Why it’s dangerous

The product may have leaks originating from the Luer component, which compromises the assurance of sterility. Using a non-sterile dialysis solution can introduce pathogens into the patient's peritoneal cavity, potentially leading to serious infections such as peritonitis.

Who’s affected

Patients undergoing peritoneal dialysis who possess Dianeal PD-2 Peritoneal Dialysis Solution in 5000 mL AMBU-FLEX II containers with yellow pull rings. Individuals using the specific recalled lots are at risk of exposure to non-sterile solution.

How to tell if you have this one

Check if you have Dianeal PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose in a 5000 mL AMBU-FLEX II container with a yellow pull ring. Verify the Product code L5B5193, NDC 0941-0411-07, and Lot number Y406734 with an expiration date of 31-Oct-2024.

  • Brand
    Baxter
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide in the USA
  • NDC
    0941-0411-05, 0941-0411-06, 0941-0411-07, 0941-0411-04, 0941-0411-11, 0941-0413-05, 0941-0413-06, 0941-0413-07, 0941-0413-01, 0941-0413-04, 0941-0415-05, 0941-0415-06, 0941-0415-04, 0941-0415-07, 0941-0415-01, 0941-0409-06, 0941-0409-05, 0941-0409-07, 0941-0409-01, 0941-0457-08, 0941-0457-02, 0941-0457-05, 0941-0457-01, 0941-0459-08, 0941-0459-02, 0941-0459-05, 0941-0459-01, 0941-0426-52, 0941-0426-53, 0941-0427-52, 0941-0427-53, 0941-0429-52, 0941-0429-53, 0941-0424-51, 0941-0424-52, 0941-0424-53, 0941-0430-51, 0941-0430-52, 0941-0430-53, 0941-0433-51, 0941-0433-52, 0941-0433-53, 0941-0484-01, 0941-0487-01, 0941-0490-01
Recall numberProduct, codes & lotsQuantity
D-1140-2023DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution 1.5% Dextrose, packaged in a) 2000 mL AMBU-FLEX II Container bag, Product Code L5B4825, NDC 0941-0409-06; b) 5000 mL AMBU-FLEX II Container bag, Product Code L5B4826, NDC 0941-0409-07; and c) 6000 mL AMBU-FLEX II Container bag, Product Code L5B9770, NDC 0941-0409-01, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.; a) Lots Y403948, Exp 30-Sep-2024; Lot Y406277, Exp 31-Oct-2024. b) Lot 408790, Exp 30-Nov-2024 and c) Lots Y403740, Y403740A, Exp 30-Sep-2024; Lots Y405638, Y405805, Y407304, Y407304A Exp 31-Oct-2024; Lots Y407717, Y407717A, Y408554, Exp 30-Nov-2024; Lot Y420075, Exp 30-Apr-2025a) 44,520; b) 60,762; c) 483,912
D-1141-2023Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose, 5000 mL AMBU-FLEX ll Container with yellow pull ring, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA Product code L5B5193 NDC 0941-0411-07; Lot Y406734, Exp 31-Oct-202422,112 bags
Based on the official FDA remedy

What to do — step by step

  1. Stop Using the Product

    Do not use the recalled Dianeal PD-2 Peritoneal Dialysis Solution if it matches the described product details and lot numbers.

  2. Contact Your Healthcare Provider

    Reach out to your doctor or dialysis center immediately to discuss alternative treatment options and next steps.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

1. Firm started the recall: Aug 11, 202312. FDA classified it Class II: Aug 29, 202323. Published in FDA’s Enforcement Report: Sep 6, 202334. FDA terminated the recall: Jul 16, 2024420232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Baxter recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1141-2023 (August 11, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1141-2023 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA